Eli Lilly:Proposed US Biosecure Act Would Affect Pharmaceutical Supply Chain Elements;Currently Do Not See It to Have Material Impact on Business
Eli Lilly:拟议的美国生物安全法案将影响药品供应链要素;目前认为该法案不会对业务产生实质性影响
Eli Lilly:Proposed US Biosecure Act Would Affect Pharmaceutical Supply Chain Elements;Currently Do Not See It to Have Material Impact on Business
Eli Lilly:拟议的美国生物安全法案将影响药品供应链要素;目前认为该法案不会对业务产生实质性影响
使用浏览器的分享功能,分享给你的好友吧